Irwin Mitchell’s Corporate Team In Gatwick Advises On Deal

Leading law firm, Irwin Mitchell, has advised on a deal which has seen Horsham-based Envision Pharma Group (“Envision”) being bought from its existing partners, the Halifax Group.

Ardian, the independent private investment company, in collaboration with GHO Capital, the specialist European investor in healthcare, has partnered with the Envision Pharma Group’s leadership team to complete the transaction.

The existing management team and employees will be reinvesting and continuing to lead the business in the next evolution of its growth.

Operating globally, Envision is a recognized partner to Medical Affairs organisations providing scientific data communication services and industry-leading technology solutions to biopharmaceutical and medical devices companies on a global basis.

Envision currently has 10 offices, three in the United Kingdom – Horsham, Wilmslow, and London; five in the United States – Philadelphia, PA, Southport, CT, Madison, NJ, Stirling, NJ, and Glastonbury, CT; and two in Asia Pacific – Tokyo and Sydney.

Established in 2001, the company employs approximately 450 team members and currently provides service and product solutions to more than 75 client companies, including 18 of the top 20 pharmaceutical companies.

Brian Hepburn, CEO of Envision, said “This partnership with Ardian and GHO Capital provides the resources, expertise, and market knowledge for Envision to realize the next stage of its development and become the leading solution provider to the Medical Affairs departments within the biopharmaceutical industry. We are uniquely positioned to support our clients via our in-depth, strategically focused, scientific communication capabilities in combination with our expanding range of technology solutions that support compliant and transparent communication of scientific evidence. With the support of Ardian and GHO Capital, we will continue to invest in these core competencies and further extend the market reach of our enterprise technology platform, iEnvisionTM.”

Faye Bargery, Corporate partner at the Gatwick office of national law firm, Irwin Mitchell, led a team which provided legal advise to Envision on the deal.

Expert Opinion
“This is an exciting deal for Envision and will no doubt signify a new and exciting chapter for the company. The business is an innovator and is now in a very strong position to expand and further establish itself in the global market place. I am dellighted to have advised on this deal and wish the company a successful future.”
Faye Bargery, Partner

John Gillie, CFO at Envision Pharma, added “Irwin Mitchell guided Envision with the utmost professionalism through all stages of the transacation. Their commercially pragmatic approach permitted the seamless continuation of our business dealings throughout the entire acquisition process”